Abstract:Prior work demonstrated that Phlpp1 deficiency alters trabecular bone mass and enhances M-CSF responsiveness, but the cell types and requirement of Phlpp1 for this effect were unclear. To understand the function of Phlpp1 within myeloid lineage cells, we crossed Phlpp1 floxed mice with mice harboring LysM-Cre. Micro-computed tomography of the distal femur of 12-week-old mice revealed a 30% increase in bone volume per total volume of Phlpp1 female conditional knockouts, but we did not observe significant changes within male Phlpp1 cKOLysM mice. Bone histomorphmetry of the proximal tibia further revealed that Phlpp1 cKOLysM females exhibited elevated osteoclast numbers, but conversely had reduced levels of serum markers of bone resorption as compared to littermate controls. Osteoblast number and serum markers of bone formation were unchanged. In vitro assays confirmed that Phlpp1 ablation enhanced osteoclast number and area, but limited bone resorption. Additionally, reconstitution with exogenous Phlpp1 suppressed osteoclast numbers. Dose response assays demonstrated that Phlpp1−/− cells are more responsive to M-CSF, but reconstitution with Phlpp1 abrogated this effect. Furthermore, small molecule-mediated Phlpp inhibition enhanced osteoclast numbers and size. Enhanced phosphorylation of Phlpp substrates—including Akt, ERK1/2, and PKCζ—accompanied these observations. In contrast, actin cytoskeleton disruption occurred within Phlpp inhibitor treated osteoclasts. Moreover, Phlpp inhibition reduced resorption of cells cultured on bovine bone slices in vitro. Our results demonstrate that Phlpp1 deficiency within myeloid lineage cells enhances bone mass by limiting bone resorption while leaving osteoclast numbers intact; moreover, we show that Phlpp1 represses osteoclastogenesis and controls responses to M-CSF.

Hematopoietic Cytoplasmic Adaptor Protein Hem1 Promotes Osteoclast Fusion and Bone Resorption in Mice

Hem1 is essential for ruffled border formation in osteoclasts and efficient bone resorption

A point mutation in the murine Hem1 gene reveals an essential role for Hematopoietic protein 1 in lymphopoiesis and innate immunity

Protein Arginine Methyltransferase 1 is Required for Maintenance of Normal Adult Hematopoiesis

ICAM-1 Deficiency in the Bone Marrow Niche Impairs Quiescence and Repopulation of Hematopoietic Stem Cells

Wild-Type P53-Induced Phosphatase 1 Plays a Positive Role in Hematopoiesis in the Mouse Embryonic Head

Dominant-negative C/ebpα and Polycomb Group Protein Bmi1 Extend Short-Lived Hematopoietic Stem/progenitor Cell Life Span and Induce Lethal Dyserythropoiesis

SHP1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Differentiation.

Notch Signaling Maintains Bone Marrow Mesenchymal Progenitors by Suppressing Osteoblast Differentiation

The histone methyltransferase ASH1L protects against bone loss by inhibiting osteoclastogenesis

Loss of BMP signaling mediated by BMPR1A in osteoblasts leads to differential bone phenotypes in mice depending on anatomical location of the bones.

Deubiquitinase MYSM1 is Essential for Normal Bone Formation and Mesenchymal Stem Cell Differentiation

Role of AML1a in Abnormal Proliferation and Differentiation of Murine Hematopoietic Cells

Bone marrow adipogenic lineage precursors are the major regulator of bone resorption in adult mice

Ablation of Tak1 in Osteoclast Progenitor Leads to Defects in Skeletal Growth and Bone Remodeling in Mice

Zeb1 maintains long-term adult hematopoietic stem cell function and extramedullary hematopoiesis

MAGED1 is a Negative Regulator of Bone Remodeling in Mice

ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice

Myeloid Lineage Ablation of Phlpp1 Regulates M-CSF Signaling and Tempers Bone Resorption in Female Mice

CARM1 deficiency inhibits osteoblastic differentiation of bone marrow mesenchymal stem cells and delays osteogenesis in mice

Phosphatase, Mg 2+ /Mn 2+ dependent 1B regulates the hematopoietic stem cells homeostasis via the Wnt/β-catenin signaling